Alkermes plc diskutieren
Alkermes plc
WKN: A1JKVH / Symbol: ALKS / Name: Alkermes / Aktie / Biotechnologie & medizinische Forschung / Mid Cap /
?
0,72 %
Alkermes (NASDAQ:ALKS) is now covered by analysts at Truist Financial Corporation. They set a "buy" rating and a $50.00 price target on the stock.
Ratings data for ALKS provided by MarketBeat
Alkermes (NASDAQ:ALKS) had its price target lowered by analysts at Deutsche Bank Aktiengesellschaft from $55.00 to $45.00. They now have a "buy" rating on the stock.
Ratings data for ALKS provided by MarketBeat
Alkermes (NASDAQ:ALKS) had its price target lowered by analysts at Wells Fargo & Company from $42.00 to $37.00. They now have an "overweight" rating on the stock.
Ratings data for ALKS provided by MarketBeat
Alkermes (NASDAQ:ALKS) had its price target raised by analysts at Truist Financial Corporation from $50.00 to $55.00. They now have a "buy" rating on the stock.
Ratings data for ALKS provided by MarketBeat
Neueste Beiträge
Barclays_PLC in Vertex Pharmaceuticals Inc. diskutieren